Toll-like receptor gene polymorphisms are associated with susceptibility to graves' ophthalmopathy in Taiwan males

BMC Medical Genetics

Volumn 11, Issue 1, 2010, Pages

  Liao, Wen Ling ^a,b   Chen, Rong Hsing ^b   Lin, Hui Ju ^a   Liu, Yu Huei ^a,b   Chen, Wen Chi ^b   Tsai, Yuhsin ^b   Wan, Lei ^a,b,c   Tsai, Fuu Jen ^a,b,c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TLR4 PROTEIN, HUMAN; TLR9 PROTEIN, HUMAN; TOLL LIKE RECEPTOR;

ADULT; ARTICLE; ENDOCRINE OPHTHALMOPATHY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; ALLELE; ASIAN; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; SEX DIFFERENCE;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GRAVES OPHTHALMOPATHY; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; SEX FACTORS; TAIWAN; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS;

EID: 78049365078     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-11-154     Document Type: Article

References (41)

1. Mishra A, Mishra SK. Multicentre study of thyroid nodules in patients with Graves' disease (Br J Surg 2000; 87: 1111-13). Br J Surg 2001, 88(2):313. 10.1046/j.1365-2168.2001.01729-3.x, 11167890.
2. Gianoukakis AG, Smith TJ. Recent insights into the pathogenesis and management of thyroid-associated ophthalmopathy. Curr Opin Endocrinol Diabetes Obes 2008, 15(5):446-452.
3. Anvari M, Khalilzadeh O, Esteghamati A, Esfahani SA, Rashidi A, Etemadi A, Mahmoudi M, Amirzargar AA. Genetic susceptibility to Graves' ophthalmopathy: the role of polymorphisms in proinflammatory cytokine genes. Eye (Lond) 2010, 24(6):1058-1063.
4. Lin MC, Hsu FM, Bee YS, Ger LP. Age influences the severity of Graves' ophthalmopathy. Kaohsiung J Med Sci 2008, 24(6):283-288. 10.1016/S1607-551X(08)70154-2, 18635413.
5. Tomer Y, Huber A. The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun 2009, 32(3-4):231-239. 10.1016/j.jaut.2009.02.007, 19307103.
6. McGrogan A, Seaman HE, Wright JW, de Vries CS. The incidence of autoimmune thyroid disease: a systematic review of the literature. Clin Endocrinol (Oxf) 2008, 69(5):687-696. 10.1111/j.1365-2265.2008.03338.x, 18673466.
7. Lim SL, Lim AK, Mumtaz M, Hussein E, Wan Bebakar WM, Khir AS. Prevalence, risk factors, and clinical features of thyroid-associated ophthalmopathy in multiethnic Malaysian patients with Graves' disease. Thyroid 2008, 18(12):1297-1301. 10.1089/thy.2008.0044, 19012471.
8. Manji N, Carr-Smith JD, Boelaert K, Allahabadia A, Armitage M, Chatterjee VK, Lazarus JH, Pearce SH, Vaidya B, Gough SC, et al. Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype. J Clin Endocrinol Metab 2006, 91(12):4873-4880. 10.1210/jc.2006-1402, 16968788.
9. Kavvoura FK, Akamizu T, Awata T, Ban Y, Chistiakov DA, Frydecka I, Ghaderi A, Gough SC, Hiromatsu Y, Ploski R, et al. Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. J Clin Endocrinol Metab 2007, 92(8):3162-3170. 10.1210/jc.2007-0147, 17504905.
10. Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 2000, 165(11):6606-6611.
11. Weetman AP. The genetics of autoimmune thyroid disease. Horm Metab Res 2009, 41(6):421-425. 10.1055/s-0029-1214415, 19343617.
12. Liu YH, Chen RH, Chen WC, Tsai Y, Wan L, Tsai FJ. Disease association of the CD103 polymorphisms in Taiwan Chinese Graves' ophthalmopathy patients. Ophthalmology 2010, 117(8):1645-1651. 10.1016/j.ophtha.2009.12.037, 20417566.
13. Chong KK, Chiang SW, Wong GW, Tam PO, Ng TK, Hu YJ, Yam GH, Lam DS, Pang CP. Association of CTLA-4 and IL-13 gene polymorphisms with Graves' disease and ophthalmopathy in Chinese children. Invest Ophthalmol Vis Sci 2008, 49(6):2409-2415. 10.1167/iovs.07-1433, 18296657.
14. Drexler SK, Foxwell BM. The role of toll-like receptors in chronic inflammation. Int J Biochem Cell Biol 2010, 42(4):506-518. 10.1016/j.biocel.2009.10.009, 19837184.
15. Caturegli P, Kimura H, Rocchi R, Rose NR. Autoimmune thyroid diseases. Curr Opin Rheumatol 2007, 19(1):44-48. 10.1097/BOR.0b013e3280113d1a, 17143095.
16. Fischer M, Ehlers M. Toll-like receptors in autoimmunity. Ann N Y Acad Sci 2008, 1143:21-34. 10.1196/annals.1443.012, 19076342.
17. O'Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev 2008, 226:10-18. 10.1111/j.1600-065X.2008.00701.x, 19161412.
18. Midwood KS, Piccinini AM, Sacre S. Targeting Toll-like receptors in autoimmunity. Curr Drug Targets 2009, 10(11):1139-1155. 10.2174/138945009789735101, 19715534.
19. Montero Vega MT, de Andres Martin A. Toll-like receptors: a family of innate sensors of danger that alert and drive immunity. Allergol Immunopathol (Madr) 2008, 36(6):347-357. 10.1016/S0301-0546(08)75868-3, 19150035.
20. Krieg AM, Vollmer J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev 2007, 220:251-269. 10.1111/j.1600-065X.2007.00572.x, 17979852.
21. Hurst J, von Landenberg P. Toll-like receptors and autoimmunity. Autoimmun Rev 2008, 7(3):204-208. 10.1016/j.autrev.2007.11.006, 18190879.
22. von Landenberg P, Bauer S. Nucleic acid recognizing Toll-like receptors and autoimmunity. Curr Opin Immunol 2007, 19(6):606-610. 10.1016/j.coi.2007.10.004, 18060756.
23. Dezsofi A, Szebeni B, Hermann CS, Kapitany A, Veres G, Sipka S, Korner A, Madacsy L, Korponay-Szabo I, Rajczy K, et al. Frequencies of genetic polymorphisms of TLR4 and CD14 and of HLA-DQ genotypes in children with celiac disease, type 1 diabetes mellitus, or both. J Pediatr Gastroenterol Nutr 2008, 47(3):283-287. 10.1097/MPG.0b013e31816de885, 18728522.
24. Hur JW, Shin HD, Park BL, Kim LH, Kim SY, Bae SC. Association study of Toll-like receptor 9 gene polymorphism in Korean patients with systemic lupus erythematosus. Tissue Antigens 2005, 65(3):266-270. 10.1111/j.1399-0039.2005.00374.x, 15730519.
25. Kang ES, Lee J. Genotypic analysis of Asp299Gly and Thr399Ile polymorphism of Toll-like receptor 4 in systemic autoimmune diseases of Korean population. Rheumatol Int 2007, 27(9):887-889. 10.1007/s00296-007-0311-z, 17235555.
26. Ng MW, Lau CS, Chan TM, Wong WH, Lau YL. Polymorphisms of the toll-like receptor 9 (TLR9) gene with systemic lupus erythematosus in Chinese. Rheumatology (Oxford) 2005, 44(11):1456-1457. 10.1093/rheumatology/kei120, 16188944.
27. Radstake TR, Franke B, Hanssen S, Netea MG, Welsing P, Barrera P, Joosten LA, van Riel PL, van den Berg WB. The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome. Arthritis Rheum 2004, 50(3):999-1001. 10.1002/art.20114, 15022344.
28. Reindl M, Lutterotti A, Ingram J, Schanda K, Gassner C, Deisenhammer F, Berger T, Lorenz E. Mutations in the gene for toll-like receptor 4 and multiple sclerosis. Tissue Antigens 2003, 61(1):85-88. 10.1034/j.1399-0039.2003.610108.x, 12622779.
29. Sheedy FJ, Marinou I, O'Neill LA, Wilson AG. The Mal/TIRAP S180L and TLR4 G299D polymorphisms are not associated with susceptibility to, or severity of, rheumatoid arthritis. Ann Rheum Dis 2008, 67(9):1328-1331. 10.1136/ard.2007.083337, 18180278.
30. Tao K, Fujii M, Tsukumo S, Maekawa Y, Kishihara K, Kimoto Y, Horiuchi T, Hisaeda H, Akira S, Kagami S, et al. Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population. Ann Rheum Dis 2007, 66(7):905-909. 10.1136/ard.2006.065961, 1955115, 17344245.
31. Urcelay E, Blanco-Kelly F, de Las Heras V, de la Concha EG, Arroyo R, Martinez A. TLR4 haplotypes in multiple sclerosis: a case-control study in the Spanish population. J Neuroimmunol 2007, 192(1-2):215-218. 10.1016/j.jneuroim.2007.10.001, 17967488.
32. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, Belmont JW, Boudreau A, Hardenbol P, Leal SM, et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007, 449(7164):851-861. 10.1038/nature06258, 2689609, 17943122.
33. Consortium TIH. A haplotype map of the human genome. Nature 2005, 437(7063):1299-1320. 10.1038/nature04226, 1880871, 16255080.
34. Project TIH. The International HapMap Project. Nature 2003, 426(6968):789-796. 10.1038/nature02168, 14685227.
35. Consortium TIH. Integrating ethics and science in the International HapMap Project. Nat Rev Genet 2004, 5(6):467-475. 10.1038/nrg1351, 2271136, 15153999.
36. Thorisson GA, Smith AV, Krishnan L, Stein LD. The International HapMap Project Web site. Genome Res 2005, 15(11):1592-1593. 10.1101/gr.4413105, 1310647, 16251469.
37. Jaen O, Petit-Teixeira E, Kirsten H, Ahnert P, Semerano L, Pierlot C, Cornelis F, Boissier MC, Falgarone G. No evidence of major effects in several Toll-like receptor gene polymorphisms in rheumatoid arthritis. Arthritis Res Ther 2009, 11(1):R5. 10.1186/ar2589, 2688235, 19134200.
38. Xu CJ, Zhang WH, Pan HF, Li XP, Xu JH, Ye DQ. Association study of a single nucleotide polymorphism in the exon 2 region of toll-like receptor 9 (TLR9) gene with susceptibility to systemic lupus erythematosus among Chinese. Mol Biol Rep 2009, 36(8):2245-2248. 10.1007/s11033-008-9440-z, 19130296.
39. Ronnblom L, Eloranta ML, Alm GV. The type I interferon system in systemic lupus erythematosus. Arthritis Rheum 2006, 54(2):408-420. 10.1002/art.21571, 16447217.
40. Allahabadia A, Daykin J, Holder RL, Sheppard MC, Gough SC, Franklyn JA. Age and gender predict the outcome of treatment for Graves' hyperthyroidism. J Clin Endocrinol Metab 2000, 85(3):1038-1042. 10.1210/jc.85.3.1038, 10720036.
41. Senthilselvan A, Chenard L, Kirychuk S, Predicala B, Schwartz DA, Burch LH, Rennie DC, Willson PJ, Dosman JA. Gender-Related Tumor Necrosis Factor-alpha Responses in Naive Volunteers With Toll-Like Receptor 4 Polymorphisms Exposed in a Swine Confinement Facility. J Interferon Cytokine Res 2009,